Abstract

BackgroundThe aberrant expression of sperm-associated antigen 9 (SPAG9) is associated with numerous cancers, including hepatocellular carcinoma (HCC). The exploration of molecules and mechanisms regulating SPAG9 expression may provide new options for HCC therapy.MethodsMiRNA target prediction programs were used to explore SPAG9-targeted miRNAs. SPAG9 and miR-141 expression were detected in HCC tissues and cell lines by Western blot and real-time PCR. Dual-luciferase reporter assay was utilized to validate SPAG9 as a direct target gene of miR-141. Cell proliferation, invasion, and migration assays were used to determine whether miR-141-mediated regulation of SPAG9 could affect HCC progression.ResultsAn inverse correlation was observed between SPAG9 and miR-141 expression in HCC tissues and cell lines. Dual-luciferase reporter assay further showed that SPAG9 was a direct target gene of miR-141. The ectopic expression of miR-141 could markedly suppress SPAG9 expression in HCC cells. MiR-141 overexpression also resulted in significantly reduced cell proliferation, invasion, and migration, and imitation of the SPAG9 knockdown effects on HCC cells. Furthermore, SPAG9 restoration in miR-141-expressing cells sufficiently attenuated the tumor-suppressive effects of miR-141. Finally, JNK activity was found to be reduced by miR-141 overexpression the same way as by SPAG9 silencing. The overexpression of SPAG9 lacking its 3′-UTR significantly restored JNK activity and its downstream genes in miR-141-transfected HCC cells.ConclusionMiR-141 suppression may cause aberrant expression of SPAG9 and promote HCC tumorigenesis via JNK pathway.Electronic supplementary materialThe online version of this article (doi:10.1186/s13046-016-0289-z) contains supplementary material, which is available to authorized users.

Highlights

  • The aberrant expression of sperm-associated antigen 9 (SPAG9) is associated with numerous cancers, including hepatocellular carcinoma (HCC)

  • SPAG9 expression level is inversely correlated with miR-141 in HCC By using three publicly available algorithms (TargetScan, miRanda, and PicTar), miR-141 was identified as a candidate miRNA that could target SPAG9

  • We examined the expression levels of miR-141 and SPAG9 in 10 randomly selected HCC tissues paired to adjacent non-cancerous liver tissues

Read more

Summary

Introduction

The aberrant expression of sperm-associated antigen 9 (SPAG9) is associated with numerous cancers, including hepatocellular carcinoma (HCC). The exploration of molecules and mechanisms regulating SPAG9 expression may provide new options for HCC therapy. Hepatocellular carcinoma (HCC) is the third cause of cancer-related mortality in the world [1]. Sperm-associated antigen 9 (SPAG9), which is a new member of the cancer testis (CT) antigen family, was involved in a c-Jun NH2-terminal kinase (JNK) signaling pathway [3, 4]. Several studies have reported an association of aberrant SPAG9 expressions in various types of human cancers including breast, thyroid, cervical, and. SPAG9 overexpression was identified to be correlated with poor prognosis and tumor progression in human HCC [11]. The underlying mechanism causing SPAG9 overexpression in HCC remains unclear

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call